LAB.00035 Multi-biomarker Disease Activity Blood Tests for Rheumatoid Arthritis

This policy addresses multi-biomarker disease activity (MBDA) blood tests for rheumatoid arthritis, such as the Vectra DA test. Anthem considers these tests investigational/experimental and not medically necessary; therefore, they are not covered. This noncoverage applies to all indications and clinical scenarios with no exceptions or medically necessary criteria.

"The use of multi-biomarker disease activity blood testing for rheumatoid arthritis (for example, Vectra DA) is consideredinvestigational and not medically necessaryin all situations."

Sign up to see full coverage criteria, indications, and limitations.